Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Crane (CR) Cash & Equivalents (2022 - 2026)

Crane has reported Cash & Equivalents over the past 5 years, most recently at $355.4 million for Q1 2026.

  • Quarterly Cash & Equivalents fell 18.32% to $355.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $355.4 million through Mar 2026, down 18.32% year-over-year, with the annual reading at $506.5 million for FY2025, 65.15% up from the prior year.
  • Cash & Equivalents was $355.4 million for Q1 2026 at Crane, down from $506.5 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $506.5 million in Q4 2025 and troughed at $218.9 million in Q2 2023.
  • The 5-year median for Cash & Equivalents is $318.2 million (2023), against an average of $326.6 million.
  • Year-over-year, Cash & Equivalents decreased 24.86% in 2024 and then surged 98.31% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $427.0 million in 2022, then fell by 22.81% to $329.6 million in 2023, then decreased by 6.95% to $306.7 million in 2024, then skyrocketed by 65.15% to $506.5 million in 2025, then fell by 29.83% to $355.4 million in 2026.
  • Per Business Quant, the three most recent readings for CR's Cash & Equivalents are $355.4 million (Q1 2026), $506.5 million (Q4 2025), and $388.2 million (Q3 2025).